Navigation Links
PositiveID Corp. Due Diligence Report - Small Cap Street
Date:9/28/2015

NEW YORK, Sept. 28, 2015 /PRNewswire/ -- Small Cap Street issues due diligence report. PositiveID Corp. (OTCQB: PSID) share closed Friday at $.028, up slightly. Trading in PSID shares was light at 2 million shares, less than half the daily average. Recent company developments has Investors in PositiveID Corp. will want to read our due diligence report. Get the report at the link below.

http://bit.ly/_PSID_Due_Diligence

Copy and paste to browser may be required.

About PositiveID Corporation

PositiveID Corporation is a life sciences tools and diagnostics company that develops biological detection systems for point-of-need testing and America's homeland defense industry. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples.

About Small Cap Street

We make the connection between sophisticated investors and high quality public companies. An issuer of reports written by financial analysts who provide a straightforward assessment of the profiled company and have pledged to remain free of influence when writing research reports. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

Safe Harbor Statement

This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements

Compliance Procedure  

Content is researched, written and reviewed on a best-effort basis by a 3rd party research provider. However, we are only human and may make mistakes. This report was prepared for informational purposes only.  A full disclaimer can be found by viewing the full analyst report. We do not hold any positions and have not been compensated in any form for this press release and coinciding reports. For more information and services provided beyond this press release please use contact information provided below. If you notice any errors or omissions, please notify us.     

Contact: editor@smallcapstreet.com


'/>"/>
SOURCE Small Cap Street
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. PositiveID Analyst Coverage Continued; Brief Report by Small Cap Traders
2. PositiveID Analyst Coverage Continued by Small Cap IR: BioThreat Detection Contender Targeting Ebola with Leading Edge Technology
3. PositiveID Poised To Carve Out Its Share of the $27.4 Billion Global Polymerase Chain Reaction (PCR) Market in 2015: Analyst Report Issued by Small Cap IR
4. PositiveID and DirectView Security Systems Enter Into Co-Marketing Agreement to Jointly Market Products to Homeland Security and First Responders
5. Todays Technical View: Elan Corp., Amarin, Seattle Genetics, and Cubist Pharma
6. BioSpecifics Technologies Corp. Announces Partnership between Auxilium and Swedish Orphan Biovitrum AB for XIAPEX in Eurasia and Africa
7. Top Drug Testing Kit Distributor, Medical Disposables Corp. Joins the Florida Staffing Association
8. Technical Study: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO Surgical Corp., and Alere Inc.
9. Global Stem Cells Group, Inc. Announces Worldwide Alliance with EmCyte Corp. to Promote In-office Regenerative Medicine Solutions
10. Genufood Energy Enzymes Corp. Announces $20 Million Equity Purchase Agreement
11. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2013 Financial Results on Tuesday, November 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):